<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39006446</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Jul</Month><Day>07</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence and Latent Viral Reactivation in Long-COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2024.07.05.24310017</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2024.07.05.24310017</ELocationID><Abstract><AbstractText>Post-acute sequelae of SARS-CoV-2 (SARS2) infection (PASC) is a heterogeneous condition, but the main viral drivers are unknown. Here, we use MENSA, Media Enriched with Newly Synthesized Antibodies, secreted exclusively from circulating human plasmablasts, to provide an immune snapshot that defines the underlying viral triggers. We provide proof-of-concept testing that the MENSA technology can capture the new host immune response to accurately diagnose acute primary and breakthrough infections when known SARS2 virus or proteins are present. It is also positive after vaccination when spike proteins elicit an acute immune response. Applying the same principles for long-COVID patients, MENSA is positive for SARS2 in 40% of PASC vs none of the COVID recovered (CR) patients without any sequelae demonstrating ongoing SARS2 viral inflammation only in PASC. Additionally, in PASC patients, MENSAs are also positive for Epstein-Barr Virus (EBV) in 37%, Human Cytomegalovirus (CMV) in 23%, and herpes simplex virus 2 (HSV2) in 15% compared to 17%, 4%, and 4% in CR controls respectively. Combined, a total of 60% of PASC patients have a positive MENSA for SARS2, EBV, CMV, and/or HSV2. MENSA offers a unique antibody snapshot to reveal the underlying viral drivers in long-COVID thus demonstrating the persistence of SARS2 and reactivation of viral herpes in 60% of PASC patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haddad</LastName><ForeName>Natalie S</ForeName><Initials>NS</Initials><Identifier Source="ORCID">0000-0002-1348-3094</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MicroB-plex Inc, Atlanta, GA, 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison-Porter</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MicroB-plex Inc, Atlanta, GA, 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quehl</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capric</LastName><ForeName>Violeta</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamothe</LastName><ForeName>Pedro A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anam</LastName><ForeName>Fabliha</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Runnstrom</LastName><ForeName>Martin C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Atlanta Veterans Affairs Health Care System, Decatur, Georgia, 30033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Truong</LastName><ForeName>Alex D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dixit</LastName><ForeName>Adviteeya N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woodruff</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lowance Center for Human Immunology, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Anting</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jiwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Doan C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hentenaar</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Caroline Y</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kyu</LastName><ForeName>Shuya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Brandon</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagman</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geoffroy</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanz</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MicroB-plex Inc, Atlanta, GA, 30332, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Atlanta Veterans Affairs Health Care System, Decatur, Georgia, 30033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lowance Center for Human Immunology, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asthma and Environmental Lung Health Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of General Internal Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metro Infectious Disease Consultants, Decatur GA 30033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ImmuneID, Inc Biotechnology Research, Waltham, MA, 02451, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cashman</LastName><ForeName>Kevin S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lowance Center for Human Immunology, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramonell</LastName><ForeName>Richard P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asthma and Environmental Lung Health Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera-Mora</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alter</LastName><ForeName>David N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roback</LastName><ForeName>John D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horwath</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Keefe</LastName><ForeName>James B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dretler</LastName><ForeName>Alexandra W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Metro Infectious Disease Consultants, Decatur GA 30033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gripaldo</LastName><ForeName>Ria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeligar</LastName><ForeName>Samantha M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Atlanta Veterans Affairs Health Care System, Decatur, Georgia, 30033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natoli</LastName><ForeName>Ted</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>ImmuneID, Inc Biotechnology Research, Waltham, MA, 02451, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Betin</LastName><ForeName>Viktoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>ImmuneID, Inc Biotechnology Research, Waltham, MA, 02451, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Rahulkumar</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vela</LastName><ForeName>Kennedy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Mindy Rodriguez</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usman</LastName><ForeName>Sabeena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varghese</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jalal</LastName><ForeName>Anum</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Saeyun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6133-5942</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Sang N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amoss</LastName><ForeName>R Toby</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daiss</LastName><ForeName>John L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-9690-7701</Identifier><AffiliationInfo><Affiliation>MicroB-plex Inc, Atlanta, GA, 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanz</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-4182-587X</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lowance Center for Human Immunology, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>F Eun-Hyung</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lowance Center for Human Immunology, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 HL116271</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI109962</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI172254</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI121252</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM095442</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AI125180</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI074492</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AI045969</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 CA260563</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CoiStatement>Declaration of Potential Conflicts of Interest FEL is the founder of MicroB-plex, Inc. and serves on the scientific board of Be Biopharma, is a recipient of grants from the BMGF and Genentech, Inc., and has served as a consultant for Astra Zeneca. NSH and AMP were scientists at MicroB-plex, Inc., Atlanta, GA and JLD is a scientist at MicroB-plex, Inc., Atlanta, GA. IS has consulted for GSK, Pfizer, Kayverna, Johnson &amp; Johnson, Celgene, Bristol Myer Squibb, and Visterra. FEL, DN, and IS are inventors of the patents concerning the plasma cell survival media related to this work (issued 9/21/21, US 11,124766 B2 PCT/US2016/036650; and issued 9/21/21, US 11,125757 B2). FEL &amp; JLD are inventors of MENSA patent U.S. Patent No. 10,247,729. April 2, 2019. FEL, NSH, JLD, &amp; IS are inventors of the MENSA PASC diagnostic provisional patent, March 28, 2024. All other authors have declared that no conflict of interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>15</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39006446</ArticleId><ArticleId IdType="pmc">PMC11245097</ArticleId><ArticleId IdType="doi">10.1101/2024.07.05.24310017</ArticleId><ArticleId IdType="pii">2024.07.05.24310017</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Omer S.B., Malani P. &amp; Del Rio C. The COVID-19 Pandemic in the US: A Clinical Update. JAMA 323, 1767&#x2013;1768 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32250388</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization, W.H. COVID-19 weekly epidemiological update, 29 December 2020. (2020).</Citation></Reference><Reference><Citation>El Sahly H.M., et al. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med 385, 1774&#x2013;1785 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482810</ArticleId><ArticleId IdType="pubmed">34551225</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh E.E., et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. The New England journal of medicine 383, 2439&#x2013;2450 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7583697</ArticleId><ArticleId IdType="pubmed">33053279</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Thambiraja T.S., Karuppanan K. &amp; Subramaniam G. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. J Med Virol 94, 1641&#x2013;1649 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34914115</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA 329, 1934&#x2013;1946 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Post COVID-19 condition (Long COVID).</Citation></Reference><Reference><Citation>Woodruff M.C., et al. Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID. Nat Commun 14, 4201 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10349085</ArticleId><ArticleId IdType="pubmed">37452024</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., et al. Distinguishing features of long COVID identified through immune profiling. Nature 623, 139&#x2013;148 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881&#x2013;895 e820 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.C., et al. Serotonin reduction in post-acute sequelae of viral infection. Cell 186, 4851&#x2013;4867 e4820 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew F., et al. Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nat Immunol 25, 607&#x2013;621 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11003868</ArticleId><ArticleId IdType="pubmed">38589621</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia-Hasler C., et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science 383, eadg7942 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., et al. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clin Infect Dis 76, e487&#x2013;e490 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest 133(2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter M.J., Mitchell R.M., Meyer Sauteur P.M., Kelly D.F. &amp; Truck J. The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications. Front Immunol 8, 630 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5451496</ArticleId><ArticleId IdType="pubmed">28620385</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliley J.L., et al. Long-Lived Plasma Cells Are Contained within the CD19(&#x2212;)CD38(hi)CD138(+) Subset in Human Bone Marrow. Immunity 43, 132&#x2013;145 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4680845</ArticleId><ArticleId IdType="pubmed">26187412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee F.E., et al. Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect. J Immunol 186, 5514&#x2013;5521 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3726212</ArticleId><ArticleId IdType="pubmed">21441455</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh I., et al. Tracking Anti-Staphylococcus aureus Antibodies Produced In Vivo and Ex Vivo during Foot Salvage Therapy for Diabetic Foot Infections Reveals Prognostic Insights and Evidence of Diversified Humoral Immunity. Infect Immun 86(2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6246899</ArticleId><ArticleId IdType="pubmed">30275008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee F.E., Falsey A.R., Halliley J.L., Sanz I. &amp; Walsh E.E. Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults. J Infect Dis 202, 1659&#x2013;1666 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3107551</ArticleId><ArticleId IdType="pubmed">20979459</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrammert J., et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. The Journal of experimental medicine 208, 181&#x2013;193 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3023136</ArticleId><ArticleId IdType="pubmed">21220454</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrammert J., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667&#x2013;671 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2515609</ArticleId><ArticleId IdType="pubmed">18449194</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad N.S., et al. Novel immunoassay for diagnosis of ongoing Clostridioides difficile infections using serum and medium enriched for newly synthesized antibodies (MENSA). J Immunol Methods 492, 112932 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33221459</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad N.S., et al. Detection of Newly Secreted Antibodies Predicts Non-recurrence in Primary Clostridioides difficile Infection. J Clin Microbiol, jcm0220121 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8925894</ArticleId><ArticleId IdType="pubmed">35107301</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyu S., et al. Diagnosis of Streptococcus pneumoniae infection using circulating antibody secreting cells. PLoS One 16, e0259644 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589192</ArticleId><ArticleId IdType="pubmed">34767590</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthukrishnan G., et al. A Bioinformatic Approach to Utilize a Patient&#x2019;s Antibody-Secreting Cells against Staphylococcus aureus to Detect Challenging Musculoskeletal Infections. Immunohorizons 4, 339&#x2013;351 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737182</ArticleId><ArticleId IdType="pubmed">32571786</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad N.S., et al. Circulating antibody-secreting cells are a biomarker for early diagnosis in patients with Lyme disease. PloS one 18, e0293203 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10624293</ArticleId><ArticleId IdType="pubmed">37922270</ArticleId></ArticleIdList></Reference><Reference><Citation>Panel, C.-T.G. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. (National Institutes of Health, 2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad N.S., et al. One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses. Immunohorizons 5, 322&#x2013;335 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9190970</ArticleId><ArticleId IdType="pubmed">34001652</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M., et al. Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation. medRxiv (2020).</Citation></Reference><Reference><Citation>Nakagawa S. &amp; Takahashi M.U. gEVE: a genome-based endogenous viral element database provides comprehensive viral protein-coding sequences in mammalian genomes. Database (Oxford) 2016(2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4885607</ArticleId><ArticleId IdType="pubmed">27242033</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G.J., et al. Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. Science 348, aaa0698 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4844011</ArticleId><ArticleId IdType="pubmed">26045439</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D.C., et al. Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture. Scientific reports 14, 3616 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10864258</ArticleId><ArticleId IdType="pubmed">38350990</ArticleId></ArticleIdList></Reference><Reference><Citation>Magri G., et al. Human Secretory IgM Emerges from Plasma Cells Clonally Related to Gut Memory B Cells and Targets Highly Diverse Commensals. Immunity 47, 118&#x2013;134 e118 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519504</ArticleId><ArticleId IdType="pubmed">28709802</ArticleId></ArticleIdList></Reference><Reference><Citation>Phad G.E., et al. Clonal structure, stability and dynamics of human memory B cells and circulating plasmablasts. Nat Immunol 23, 1076&#x2013;1085 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9276532</ArticleId><ArticleId IdType="pubmed">35761085</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758&#x2013;763 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Koren I., et al. The Eukaryotic Proteome Is Shaped by E3 Ubiquitin Ligases Targeting C-Terminal Degrons. Cell 173, 1622&#x2013;1635 e1614 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6003881</ArticleId><ArticleId IdType="pubmed">29779948</ArticleId></ArticleIdList></Reference><Reference><Citation>Larman H.B., et al. Autoantigen discovery with a synthetic human peptidome. Nat Biotechnol 29, 535&#x2013;541 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4169279</ArticleId><ArticleId IdType="pubmed">21602805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanz T.V., et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321&#x2013;327 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9382663</ArticleId><ArticleId IdType="pubmed">35073561</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedran D., Bedran G. &amp; Kote S. A Comprehensive Review of Neurodegenerative Manifestations of SARSCoV-2. Vaccines (Basel) 12(2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10974019</ArticleId><ArticleId IdType="pubmed">38543856</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant R.A., et al. Prolonged exposure to lung-derived cytokines is associated with activation of microglia in patients with COVID-19. JCI Insight 9(2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11141878</ArticleId><ArticleId IdType="pubmed">38502186</ArticleId></ArticleIdList></Reference><Reference><Citation>Rippee-Brooks M.D., et al. Viral Infections, Are They a Trigger and Risk Factor of Alzheimer&#x2019;s Disease? Pathogens 13(2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10974111</ArticleId><ArticleId IdType="pubmed">38535583</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 380, e072529 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y. &amp; Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol 10, 311&#x2013;321 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B. &amp; Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med 28, 583&#x2013;590 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R., et al. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine 56, 101783 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9830133</ArticleId><ArticleId IdType="pubmed">36643619</ArticleId></ArticleIdList></Reference><Reference><Citation>Syed U., et al. Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care. BMC Med 21, 363 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10512476</ArticleId><ArticleId IdType="pubmed">37735654</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesch F., et al. Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study. Clin Rheumatol 42, 2905&#x2013;2914 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10497688</ArticleId><ArticleId IdType="pubmed">37335408</ArticleId></ArticleIdList></Reference><Reference><Citation>Middeldorp J.M. Epstein-Barr Virus-Specific Humoral Immune Responses in Health and Disease. Current topics in microbiology and immunology 391, 289&#x2013;323 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26428379</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsten C.B., et al. Evolution of functional antibodies following acute Epstein-Barr virus infection. PLoS pathogens 18, e1010738 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9481173</ArticleId><ArticleId IdType="pubmed">36067220</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiegers A.K., Sticht H., Winkler T.H., Britt W.J. &amp; Mach M. Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus. Journal of virology 89, 361&#x2013;372 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4301166</ArticleId><ArticleId IdType="pubmed">25320309</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilleri D., et al. Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection. PloS one 8, e59863 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3612069</ArticleId><ArticleId IdType="pubmed">23555812</ArticleId></ArticleIdList></Reference><Reference><Citation>Macagno A., et al. Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128&#x2013;131A complex. Journal of virology 84, 1005&#x2013;1013 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798344</ArticleId><ArticleId IdType="pubmed">19889756</ArticleId></ArticleIdList></Reference><Reference><Citation>Belshe R.B., et al. Correlate of immune protection against HSV-1 genital disease in vaccinated women. The Journal of infectious diseases 209, 828&#x2013;836 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3935479</ArticleId><ArticleId IdType="pubmed">24285844</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>